Alterity Therapeutics Ltd (ASX:ATH)
APAC company
Share Price Chart
- Chart currently unavailable -
Market Info - ATH
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ATH
- Market CapAUD0.000m
- SymbolASX:ATH
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINAU0000043945
Company Profile
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434).Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson’s disease gastrointestinal neuropathology.
Latest ATH news
Currently there for this company. Visit our news hub for other news .